Related Experiment Video
Updated: Aug 18, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Emerging role of RAB GTPases in cancer and human disease
Kwai W Cheng1, John P Lahad, Joseph W Gray
1Department of Molecular Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77054, USA. kwcheng@mdanderson.org
Abstract:
Emerging evidence implicates alterations in the RAB small GTPases and their associated regulatory proteins and effectors in multiple human diseases including cancer. We have recently shown that RAB25, located at chromosome 1q22, is amplified at the DNA level and overexpressed at the RNA level in ovarian and breast cancer. These changes correlated with a worsened outcome in both diseases. In addition, enforced expression of RAB25 in both breast and ovarian cancer cells decreased apoptosis and increased proliferation and aggressiveness in vivo, potentially explaining the worsened prognosis. A better understanding of genetic alterations as well as the physiologic and pathophysiologic roles of RAB GTPases may open new opportunities for therapeutic intervention and better outcomes.
Insights
RAB25 gene alterations are linked to poor outcomes in ovarian and breast cancers. Increased RAB25 expression promotes cancer cell survival and growth, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- RAB small GTPases and their regulators are implicated in human diseases, including cancer.
- Genetic alterations in RAB GTPases may offer therapeutic targets.
Purpose of the Study:
- To investigate the role of RAB25 in ovarian and breast cancer.
- To correlate RAB25 alterations with patient prognosis and tumor behavior.
Main Methods:
- Analysis of DNA and RNA levels of RAB25 in cancer tissues.
- Functional studies involving enforced expression of RAB25 in cancer cell lines.
- In vivo assessment of cancer cell proliferation, apoptosis, and aggressiveness.
Main Results:
- RAB25 is amplified and overexpressed in ovarian and breast cancers.
- RAB25 alterations correlate with worsened patient outcomes.
- Enforced RAB25 expression reduces apoptosis and increases proliferation and aggressiveness in vivo.
Conclusions:
- RAB25 is an oncogenic factor in ovarian and breast cancers.
- Understanding RAB GTPase roles can lead to new cancer therapies.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Ras Gene
Ras is a superfamily...
Rab Cascades
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...
